References
[1]. F.J.Mincione, L.Menabuoni,C.T. Sepuran, . Clinical applications of the carbonic anhydrase inhibitors in ophthalmology. In “Carbonic anhydrase, its inhibitors an activators”, Supuran, C.T.; Scozzafava, A.j Conway, J. Eds. CRC Press, Boca Raton (FL), 2004, pp 243-254.
[2]. B.W.Clare, C.T.Supuran,.; QSAR studies of Sulfonamide Carbonic anhydrase inhibitors, in Supuran, C.T.; Scozzatava, A, Conway, J. (Eds) Carbonic anhydrase; its inhibitors and Activators, CRC Press, Boca Raton: F1, USA, 2004.
[3]. C.T.Supuran, A. Scozzafava, A. Casini, . Development of sulfonamide carbonic anhydrade inhibitors (CAIs) In “Carbonic anhydrase, its inhibitors and activators”, C.T. Supuran, A.Scozzafava, J.Conway, Eds. CRC Press, Boca Raton (FL), 2004, pp. 67
[4]. Willams D.A.,LamkeT.L.; foy’s principle of medicinal, fifth Edition
[5]. C.T.Supuran, A. Scozzafava, .L. Menabuoni, F. Mincione, .F. Briganti, .G. Mincione, . ‘Syunthesis and ocular pharmacology of a new class of water soluble, topically effective intraocular pressure lowring sulfonamides incorporating picolinoyl moieties’. European Journal of Pharmaceutical science volume 8 p 317 – 328 (1999)
[6]. S.Singh, J. Singh, M. Ingle, R. Mishra,;P.V.Khadikar, . ‘QSAR Study of Carbonic anhydrase inhibition: predicting log ki (hCAI) by using (-SO2NH2) NMR chemical shift on a molecular descriptor. Arkivoc 2006 (xvi) 1-15.
[7]. P.V.Khadikar, V. Sharma, S. Karmarkar ,C.T. Supuran, Novel use of chemical shift in NMR as molecular descriptor: a first report on modeling carbonic anhydrase inhibitory activity and related parameters. Bio-organic and medicinal chemistry letters 15(2005) 931-936
[8]. P.V.Khadikar, M. Lakhwani,,P. Thakur, Computational Modeling of the carbonic anhydrase inhibition using C-13 NMR. Presented a research paper the 7th international conference on the carbonic anhydrase at university of Florida St. Augustine, October 2006.
[9]. P.V.Khadikar,V. Sharma, R.G. Verma, , Novel estimation of Lipophilicity using 13C NMR chemicalshifts as Molecular Descriptor, Bio org. Med. Chem. Letters, 2005, 15, 421-425
[10]. C.Daniels, F.S. Wood, Fitting Equations to Data, New York, 1980
[11]. N.R.Draper, H. Smith, Applied Regression Analysis, 2nd Ed., Wiley, New York, 1981.
[12]. C.Hansch, M. Yoshimoto, J: Med. Chem. 17, 1160-1167 (1974)
[13]. H.Kubinyi, J. Med. Chem. 19, 587-600 (1976)
[14]. Y.C.Martin, Quantitative Drug Design, A Critical introduction, Medicinal Research Series, Vol.8, Marcel Dekker, New York, 1978.
[15]. H.Kubinyi, Quant. Struct. Act. Relat., 7 121-133 (1988)
[16]. J.D.Jobson, , Regression and experimental design volume 1-2 Page 270.
[17]. S.Chatterjee, A.S. Hadi,B. Price, Regression Analysis by examples, 3rd ed; Wiley; New York, 2000.
[18]. P.V.Khadikar, S. Sharam, V. Sharma, S.Joshi, I. Lukovits, H. Kaveshwar, A QSAR study on the effect of Benzohydro oxamic Acid on DNA synthesis, Bull Soc. Chem. Belg. 1997, 106, 767-772.
[19]. N.S.Sagore, A. Sikarwar, P.V.Khadikar, QSAR Modeling of Salicylhydroxamic Acid Derivatives using Balban Index (J) Oxid. Commun. 2001, 24, 28-27
[20]. A.Thakur, M.Thakur,P.V. Khadikar, C.T. Supuran,P.Sudele, QSAR study on Benzene sulphonamide Carbonic Anhydrase Inhibitors. Topological Approach using Balaban Index , Bioorg.Med. Chem., 2004, 12, 789-793
[21]. A.T.Balaban, P.V. Khadikar, C.T. Supuran, A. Thakur, M. Thakur, Study on Supramolecular complexing ability vis a vis estimation of IPka of substituted sulfonamides. Dominating Role of Balaban Index (J) Bioorg. Med. Chem. Letters, 2005, 15, 3966- 3973
[22]. F.J.Mincione, L.Menabuoni,C.T. Sepuran, . Clinical applications of the carbonic anhydrase inhibitors in ophthalmology. In “Carbonic anhydrase, its inhibitors an activators”, Supuran, C.T.; Scozzafava, A.j Conway, J. Eds. CRC Press, Boca Raton (FL), 2004, pp 243-254.
[23]. B.W.Clare, C.T.Supuran,.; QSAR studies of Sulfonamide Carbonic anhydrase inhibitors, in Supuran, C.T.; Scozzatava, A, Conway, J. (Eds) Carbonic anhydrase; its inhibitors and Activators, CRC Press, Boca Raton: F1, USA, 2004.
[24]. C.T.Supuran, A. Scozzafava, A. Casini, . Development of sulfonamide carbonic anhydrade inhibitors (CAIs) In “Carbonic anhydrase, its inhibitors and activators”, C.T. Supuran, A.Scozzafava, J.Conway, Eds. CRC Press, Boca Raton (FL), 2004, pp. 67
[25]. Willams D.A.,LamkeT.L.; foy’s principle of medicinal, fifth Edition
[26]. C.T.Supuran, A. Scozzafava, .L. Menabuoni, F. Mincione, .F. Briganti, .G. Mincione, . ‘Syunthesis and ocular pharmacology of a new class of water soluble, topically effective intraocular pressure lowring sulfonamides incorporating picolinoyl moieties’. European Journal of Pharmaceutical science volume 8 p 317 – 328 (1999)
